期刊文献+

配制置换液与Online置换液在连续性静脉-静脉血液滤过中的应用比较研究 被引量:3

下载PDF
导出
摘要 目的比较配制置换液和Online联机生产的置换液在制备方法、临床疗效、安全性方面的异同,为临床医师提供合适的置换液解决方案。方法选择我院ICU住院患者22例,随机分为A组与B组,建立临时性血管通路,行连续性静脉-静脉血液滤过治疗。A组患者使用Online置换液,B组患者使用配制置换液。分别于置换液制备的0h,4h,8h,12h观察置换液外观变化,并测定置换液的电解质浓度以及内毒素,12h时进行细菌培养。检测患者治疗前后血尿素氮、肌酐、电解质及血气的变化,并进行APACHE评分。结果两组置换液相关指标数值在12h内各时间点与制备时比较差异无统计学意义(P>0.05)。内毒素在各时点检测<0.1U/ml,细菌培养阴性。两组患者同组内治疗前后比较尿素氮、肌酐明显下降(P<0.05);酸碱情况趋于稳定;钠、氯、钙、镁离子浓度稳定;APACHEII评分有所下降(P<0.05)。治疗后A组与B组相比,前者钾较低,酸碱度偏碱(P<0.05),其余指标两组比较差异无统计学意义(P>0.05)。结论两种置换液在有效性、安全性方面差异无统计学意义。Online置换液具有制备方便,成本低廉的突出优点,而配制置换液的优点主要是个体化,更适合于病情变化快的危重患者。
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2005年第5期740-742,共3页 Journal of Sichuan University(Medical Sciences)
  • 相关文献

参考文献6

  • 1陶静.高容量血液滤过[J].肾脏病与透析肾移植杂志,2003,12(1):81-84. 被引量:52
  • 2Lemeke D. Methods for the detection of endotoxins present during extracorporeal circution. Nephro Dial Transplant,1994;91(Suppl 2):90.
  • 3Heering P, Ivens K, Thumer O, et al. Acid-base balance and substitution fluid during continuous hemofiltration,Kidney International,1999;56(S72):37.
  • 4Barenbrock M. Effect of bicarbonate-and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney International, 2000;58:1751.
  • 5Roy T. Technical and microbiological safety of Online hemodiafiltration:a European perspective. Seminars in Dialysis,1999;12(S1):81.
  • 6Maccariello E,Rocha E,Dalboni M,et al. Customized bicarbonate buffered dialysate and replacement solution for continuous renal replacement therapy:effect of crystallization on the measured levels of electrolytes and buffer. Artifical Organs,2001;25(11):870.

二级参考文献23

  • 1Von Andrian UH, Mackay CR. T-cell function and migration. N Engl J Med,2000,343:1 020
  • 2Grootendorst AF, van Bommel EFH, van der Hoven B et al. High volune hemofiltration improves right ventricular function of endotoxin-induced shock in the pig. Intensive Care Med,1992,18:235
  • 3Schetz M. Non-indications for continuous renal replacement therapy. Kidney Iht, 1999,56:S88
  • 4Bellomo R, Baldwin I, Ronco C. High volume hemofiltration. Contrib Nephrol ,2001,132:375
  • 5Honore PM, Jamez J, Wauthier M et al. Prospective evaluation of shortterm, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med,2000,28:3 581
  • 6Swinford RD, Baid S, Pascual M. Dialysis membrane adsorption during CRRT. AJKD, 1997(Suppl 4) ,30:s32
  • 7Slivester W. Mediator removal with CRRT: Complement and cytokines.AJKD, 1997(Suppl 4) ,30:s38
  • 8Rogiers P. Zhang H. Smail N et al. Continuous veno-venous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor- attenuation during endotoxic shock. Crit Care Med, 1999,27:1848
  • 9Cole L, Bellomo R, Journois D et al. High-volume hemofiltration in human septic shock. Intensive Care Med,2001,27(6) :978
  • 10Gasche Y, Pascual M, Srter PM et al. Complement depletion during hemofiltration with polyacrilonitrile membranes. Nephrol Dial Transplant,1996,11:117

共引文献51

同被引文献33

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部